Laura J. Zitella, MS, RN, ACNP-BC, AOCN, explains that later cytopenias should be monitored in patients undergoing CAR T-cell ...

The FDA has approved subcutaneous daratumumab and hyaluronidase-fihj (Darzalex Faspro) for use in patients with high-risk ...

An advanced practice provider (APP)-led peer review quality assurance (QA) committee was found to be feasible and identified ...

The frontline addition of cancer vaccine IO102-IO103 to pembrolizumab demonstrated an increase in PFS in patients with advanced melanoma. The addition of the investigational immunomodulatory cancer ...

Integrative oncology is a patient-centered approach to cancer care that looks at the whole patient and combines their ...

Sequencing treatment for patients with relapsed or refractory multiple myeloma depends on the patient’s disease and history, explained Lisa Hwa Christenson, DNP, APRN, CNP, associate professor of ...

Among lymphoma survivors experiencing chronic fatigue, a multidisciplinary intervention program has been found to have a ...

Imatinib (Gleevec) showed durable efficacy in advanced gastrointestinal stromal tumors (GIST), with complete response (CR) or complete resection yielding a twofold increase in median survival, ...

Opening discussions about priorities and learning about inclusive language are among the most impactful steps an advanced ...

While at 3 months fewer patients in supervised physical activity arm reported visual analog scale loss of energy (45% vs 62%) ...